Explore New Innovations with Dahua Full-color Camera
22.11.2022 15:45:00 EET | Business Wire | Press release
Dahua Technology, a world-leading video-centric smart IoT solution and service provider, has been accelerating the innovation and exploration of Full-color Technology. Featuring TiOC, Panoramic, Zoom and 4K, the new generation of Dahua full-color series provides a wide range of low-light solutions that integrate different intelligent technologies to solve pain points in various scenarios, allowing installers and end users to choose the ideal solution that best suits their needs.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221121005376/en/
Inadequate availability of light is one of the major challenges of every monitoring system. Images taken under such lighting condition are often not clear, have detail loss, and even contain noise, making it difficult to detect or trace back targets in case of an event. The Dahua Full-color cameras were developed to address these demanding monitoring challenges. With remarkable offerings such as dual lens, vari-focal lens, 4K resolution, and AI features, this technology offers a wide-range of products and solutions that can effectively solve the arduous monitoring pain points of end-users and provide clear and vivid images of the monitored scene 24/7. (Photo: Business Wire)
Full-color + TiOC: effective deterrent against intruders
The Dahua TiOC (three-in-one camera) integrates Smart Dual Illuminators, Active Deterrence, and AI to offer a pro-active monitoring solution that can effectively warn off intruders. The combination of Dahua’s industry-leading full-color technology with powerful AI functions and real-time Active Deterrence warnings makes it suitable for places that require 24/7 security, such as villas, shops, warehouses, etc., helping to reduce false alarm rates, improve target search efficiency, generally optimize system operation, and reduce costs.
Full-color + Panoramic: the whole scene in vivid color
The Dahua Full-color Dual Lens 180° Panoramic PTZ & IPC are equipped with dual sensors that deliver a 180-degree field of view. It adopts the Dahua pixel-level seamless fusion algorithm to splice images into horizontal 180° monitoring scene, providing users with brilliant full-color and panoramic images. Featuring wide-area coverage, it is an excellent alternative to daunting installation of multiple cameras just to cover a large scene. Thanks to Full-color Technology, the intelligent panoramic camera can provide clear color images even at night, which is essential for 24/7 continuous monitoring in large application scenarios such as squares, hallways, and parking lots.
Full-color + ZOOM: vari-focal zoom in with vivid color
The Dahua Full-color Vari-focal Camera boasts approx. 5x optical zoom capability and auto-focus function. These cameras provide clear monitoring scene details even after zooming in, capture vivid color images in dark environments, and also allow users to directly adjust the camera’s focus according to the actual scene, which is convenient and time-saving.
Full-color + 4K: Realistic 4K UHD image quality
The Dahua Full-color 4K Camera delivers enhanced color images and video footages 24/7. It adopts 1/1.2” image sensor (currently Dahua's best low-light IPC sensor) that provides 110% pixel size increase compared to common 8MP sensor. Combined with a F1.0 large aperture, more available light can be captured to provide clear and vivid images, which is conductive to accurate video analysis.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221121005376/en/
Contact information
Zoe Xu (xu_shuyi@dahuatech.com )
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FERM FOOD Acquires Orkla’s Former Site and Scales Up: Up to 20,000 Tonnes of Fermented Ingredients Per Year11.3.2026 08:00:00 EET | Press release
Danish ingredient producer FERM FOOD is acquiring Orkla’s former manufacturing site in Skovlund, Denmark, effective 1 April 2026. The acquisition provides new production facilities to expand the output of fermented plant-based ingredients for the food industry — driven by export demand that has emerged faster than expected. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310904877/en/ Jens Legarth (CEO), Rikke Matthiesen (CSO), and Torbjørn Tyndkjær-Thomsen (Food & Process Developer) at FERM FOOD’s new production facilities. “We have outgrown our current facilities. With the Skovlund site, we can supply many more food manufacturers in Denmark and abroad. Global interest has developed faster than we expected — and that is why we are scaling up now,” says Jens Legarth, CEO of FERM FOOD. Once fully ramped up, the new fermentation facility is expected to reach an annual capacity of up to 20,000 tonnes, depending on product mix
Galderma Buys Back Shares Worth CHF 232 Million in the Context of Accelerated Bookbuild Offering11.3.2026 08:00:00 EET | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it has agreed to repurchase 1.6 million shares at a price of CHF 143.75 per share for a total consideration of CHF 232 million in the context of the accelerated bookbuild offering (“ABO”) of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (Private Equities Department) and Auba Investment Pte. Ltd. (all together the “Selling Shareholders”) launched yesterday evening. The repurchase was made at the same price per share determined by the bookbuilding offering. As a result of yesterday evening’s ABO, the Selling Shareholders have fully divested their remaining stake in Galderma. The repurchase, which is expected to settle on March 13 is being financed by Galderma’s existing liquidity on hand and will not affect the company’s ability to deliver on its strategic and financing priorities. The shares will be held in treasury for future use in connection with Galderma's employe
Thales Launches SkyDefender: The Integral Air and Missile Defence Dome With Artificial Intelligence11.3.2026 08:00:00 EET | Press release
As air and missile threats are evolving faster than ever, from slow-moving drones to hypersonic missiles, attacks are becoming increasingly complex, saturating and unpredictable. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260310398606/en/ SkyDefender © Thales Thales SkyDefender provides full protection against all types of air threats, from a few kilometres to several thousands of kilometres: Short-range: for protection of forces, vital assets and sensitive sites: ForceShield creates a real protection bubble against lower layer and surface threats at very short- and short-range, such as drones. Medium-range: for protection at theatre-level defence: SAMP-T NG by eurosam1 with up to 150 km engagement range, including Thales’ powerful Ground Fire radar with 350 km range and 360°/90° coverage against medium-range defence. Long-range: for protection against long-range threats with early-warning capabilities: a unique capacity
Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan11.3.2026 08:00:00 EET | Press release
Curatis Holding AG (SIX: CURN) and Neupharma Co., Ltd. (“Neupharma”), a Japanese pharmaceutical company specializing in oncology, immunology, pulmonology and cardiology disorders, today announce an exclusive license and development agreement for corticorelin (C-PTBE-01) in Japan. Under the terms of the agreement, Neupharma will receive exclusive rights to develop and commercialize corticorelin for the treatment of peritumoral brain edema (PTBE) in Japan. PTBE is a tumor-associated condition for which no approved targeted therapies currently exist. Neupharma will finance and conduct a pivotal clinical trial in Japan to support filing for approval in Japan. Curatis will receive upfront and milestone payments for the achievement of regulatory and commercial targets totaling up to CHF 83.5 million, as well as royalties on future sales in Japan of up to 20%. The agreement stipulates that corticorelin is planned to be introduced in Japan initially for children and adolescents. A meeting with
Galderma Completes Successful Placement of EUR 500 Million Eurobond11.3.2026 07:55:00 EET | Press release
Galderma Group AG (SWX:GALD): NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION. Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced the successful placement of a single-tranche EUR 500 million Eurobond. The bond has a 5-year maturity and carries a fixed-rate annual coupon of 3.375%. The Eurobond was placed on March 10, 2026, with settlement expected on March 17, 2026, and will be listed on the SIX Swiss Exchange. Citigroup, ING, J.P. Morgan and RBC Capital Markets jointly led the transaction. Net proceeds from the transaction will be used to fully repay Galderma’s existing bank term loan issued in connection with the company’s initial public offering in March 2024. The transaction represents the final step in Galderma’s refinancing process, having obtained two investment grade credit ratings. Galderma is currently rated ‘BBB’ (stable outlook) by Fitc
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom